Navigation Links
ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference

ADDISON, Texas, Dec. 9 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today that a presentation on Altrazeal(TM) Transforming Powder Dressing will be made at the prestigious 10th Annual Wound Healing Science and Industry Conference to be held December 10-13, 2009 in St Thomas, U.S. Virgin Islands. The presentation will include research on advanced applications of Altrazeal(TM) related to the development of future products in drug delivery and tissue engineering. This conference is organized as a collaborative series of symposia and poster presentations with many of the top scientists and clinicians in the field of wound care discussing advanced research and treatments. Conference details and the program can be found at

John V. St. John, PhD, Vice President of Research and Development for ULURU Inc., is part of a limited number of industry scientists who have been invited to make a podium presentation. The presentation to be made by Dr. St. John will detail the physical and chemical nature of Altrazeal(TM) and highlight the research performed at ULURU Inc. on the development of advanced products allowing controlled release of growth factors. Commenting on the meeting, Peter Sheehan, MD, a conference organizer, stated: "The meeting is a gathering of elite scientists and industry leaders to exchange ideas on new directions in the field of Wound Healing. It's really become the Davos of Wound Healing."

Renaat Van den Hooff, President and CEO of ULURU Inc., commented: "It is very prestigious for our company that Dr. St. John has been invited to participate in this leading symposium. I believe it is a tribute to the novelty of Altrazeal(TM) and the Nanoflex technology, and a recognition that Altrazeal(TM) has the potential to impact the way wounds will be more effectively treated in the future. We remain committed to the development of advanced therapies in wound healing and to the integration of the latest scientific advances into our future product development programs."

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and OraDisc(TM) transmucosal delivery system. For further information about ULURU Inc., please visit our website at For further information about Altrazeal(TM), please visit

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the effectiveness in wound healing of Altrazeal(TM). These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, and other reports filed by us with the Securities and Exchange Commission.

Contact: Company
Renaat Van den Hooff
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
2. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
3. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
4. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
5. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
6. Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora
7. Arpida Invited to Present Data on Iclaprim at Scientific Conference
8. Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
9. Women Invited to Join New Health Registry to Advance Research
10. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
11. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
Post Your Comments:
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):